One MRI scan to rule them all? new study tests organ health in diabetes
NCT ID NCT04137705
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a single, standardized MRI scan can reliably measure body composition and the health of multiple organs—like the liver, pancreas, heart, and kidneys—in people with type 2 diabetes and healthy volunteers. 43 participants were scanned twice on the same machine and on different machines to check how repeatable the measurements were. The goal was to see if this approach could be a useful tool for future research or clinical care, not to treat the disease itself.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this MRI method could help doctors better understand how type 2 diabetes affects multiple organs, potentially leading to earlier detection or monitoring.
- What could go wrong
- This is a small, early-stage study focused on measuring reproducibility, not on treating or curing diabetes. The results may not apply to all patients or scanners.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
43 people
The number who actually took part.
- Started
-
Nov 2019
- Finished
-
Nov 2023
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Adult volunteers, including healthy volunteers and individuals with Type 2 Diabetes (T2D).
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Any person over 18 years of age. * Participant is willing and able to give informed consent for participation in the investigation. * EITHER: Participant has Type 2 Diabetes OR: Person is a healthy volunteer Exclusion Criteria: * The participant may not enter the investigation if they have any contraindication to magnetic resonance imaging (incl. pregnancy, extensive tattoos, pacemaker, shrapnel injury, severe claustrophobia). * Any other cause, including a significant disease or disorder which, in the opinion of the investigator, may either put the participant at risk because of participation in the investigation, or may influence the result of the investigation, or the participant's ability to participate in the investigation
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Type 2 diabetes are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beaver House
Oxford, OX1 2EH, United Kingdom
-
Gemini One
Oxford, OX4 2LL, United Kingdom
-
Oxford Centre for Magnetic Resonance
Oxford, OX3 9DU, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can mindfulness and yoga rewire diabetes habits?
- Can a vegan diet delivered online help people with type 2 diabetes?
- Tiny horses, big lessons: can ponies help kids tame diabetes?
- Gut microbes in pregnancy and infancy: a window into lifelong health?
- A blood test at 50 could flag your risk of five diseases. can an app stop them?
- Chatbot coach takes aim at diabetes risk after pregnancy